Elsevier,
Water Research X, Volume 28, 1 September 2025
This study explores the integration of Generative Artificial Intelligence (GenAI) in water distribution networks, identifying opportunities for enhancing information retrieval, improving water quality management, implementing predictive maintenance, and optimizing operations, while also addressing challenges related to data quality, scalability, and the need for expertise in both engineering and AI, ultimately providing insights for water utilities and policymakers on leveraging GenAI responsibly.
Elsevier,
Journal of the Society for Cardiovascular Angiography and Interventions, Volume 4, September 2025
The 30-day Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) has been used to risk-stratify patients undergoing transcatheter aortic valve replacement (TAVR). Whether surgical mortality risk predicts stroke and neurocognitive outcomes following TAVR is unknown. We evaluated the association between STS-PROM and clinical outcomes, including stroke, acute brain injury on diffusion-weighted magnetic resonance imaging (DW-MRI), and cognitive decline in patients undergoing TAVR.
Elsevier,
Results in Engineering, Volume 27, September 2025
This study introduces a new, safe, affordable, and non-invasive device designed to detect and monitor early signs of Alzheimer's disease. Unlike traditional tests like MRI or CT scans, this device uses microwaves to examine the brain.
Elsevier,
Brain Network Disorders, Volume 1, Issue 3, September 2025, Pages 150-166
The article discusses the potential of neuron-derived extracellular vesicles (NDEVs) as diagnostic biomarkers for Alzheimer's disease (AD). NDEVs carry pathological proteins like amyloid-? and Tau, and their levels in bodily fluids can distinguish AD patients from healthy controls and predict disease onset.
Elsevier,
Journal of Prevention of Alzheimer's Disease, Volume 12, 1 September 2025
The TRAILBLAZER-ALZ 6 study found that a modified donanemab titration regimen significantly reduced ARIA-E frequency and severity compared to standard dosing, while maintaining similar amyloid reduction. Safety profiles were comparable between the two arms. The modified titration approach may help mitigate risks associated with amyloid-targeting therapies in early Alzheimer's disease.
Elsevier,
Trends in Food Science and Technology, Volume 163, September 2025
Consumers' negative emotions like food neophobia and disgust, driven by evolutionary risk assessment mechanisms, hinder acceptance of future foods. To promote sustainable food innovation, these behavioral responses must be addressed, as novel foods often signal danger and are readily rejected despite their safety.
